Elsner D, Stewart D J, Sommer O, Holtz J, Bassenge E
Hypertension. 1986 Nov;8(11):1003-14. doi: 10.1161/01.hyp.8.11.1003.
The involvement of postsynaptic alpha 2-adrenergic receptors in the adrenergic constriction of the capacitance vessels was studied in anesthetized, spontaneously breathing dogs under ganglionic blockade (hexamethonium, 10 mg/kg + 10 mg/kg/hr; methylatropine, 0.5 mg/kg). Effective vascular compliance was measured as an indicator of venous tone (blood volume was varied by +/- 4 ml/kg in an 11-minute cycle of infusion, withdrawal, withdrawal, and reinfusion) and was calculated from the correlation between the observed changes in central venous pressure and the changes in blood volume. Sympathetic activity and central venous pressure were lower and effective vascular compliance was higher than values in untreated conscious dogs. The alpha 2-agonist UK 14,304 (5-bromo-6-[imidazolin-2-ylamino]-quinoxaline; 0.04 and 0.12 micrograms/kg/min; n = 6) dose-dependently lowered compliance and increased central venous pressure to levels found in conscious dogs, as did the alpha 1-agonist methoxamine (10 and 30 micrograms/kg; n = 6). Rauwolscine (alpha 2-antagonist), 0.3 mg/kg, significantly attenuated the effects of UK 14,304, but not those of methoxamine, while prazosin (alpha 1-antagonist), 0.12 mg/kg, attenuated the effects of methoxamine, but not those of UK 14,304 (n = 6 each). Under beta-blockade (nadolol, 2 mg/kg; n = 12) venous tone was increased to about physiological levels by norepinephrine, 0.15 micrograms/kg/min i.v., or by neuronal norepinephrine release induced by tyramine, 10 micrograms/kg/min i.v. These increases were significantly attenuated by prazosin as well as by rauwolscine and were abolished by a combination of both. These results indicate that postsynaptic alpha 2-adrenergic receptors (in addition to alpha 1-adrenergic receptors) are functional in the venous system in vivo and contribute substantially to adrenergic sympathetic and humoral regulation of venous tone.
在神经节阻断(六甲铵,10mg/kg + 10mg/kg/小时;甲基阿托品,0.5mg/kg)下,对麻醉的自主呼吸犬研究了突触后α2 - 肾上腺素能受体在容量血管肾上腺素能收缩中的作用。有效血管顺应性作为静脉张力的指标进行测量(在11分钟的输注、回撤、回撤和再输注周期中,血容量以±4ml/kg变化),并根据中心静脉压的观察变化与血容量变化之间的相关性进行计算。交感神经活动和中心静脉压低于未治疗的清醒犬,有效血管顺应性高于未治疗的清醒犬。α2 - 激动剂UK 14,304(5 - 溴 - 6 - [咪唑啉 - 2 - 基氨基] - 喹喔啉;0.04和0.12μg/kg/分钟;n = 6)剂量依赖性地降低顺应性并将中心静脉压升高至清醒犬的水平,α1 - 激动剂甲氧明(10和30μg/kg;n = 6)也有此作用。0.3mg/kg的育亨宾(α2 - 拮抗剂)显著减弱UK 14,304的作用,但不减弱甲氧明的作用,而0.12mg/kg的哌唑嗪(α1 - 拮抗剂)减弱甲氧明的作用,但不减弱UK 14,304的作用(每组n = 6)。在β - 阻断(纳多洛尔,2mg/kg;n = 12)下,静脉滴注0.15μg/kg/分钟的去甲肾上腺素或静脉注射10μg/kg/分钟的酪胺诱导的神经元去甲肾上腺素释放使静脉张力增加至约生理水平。这些增加被哌唑嗪以及育亨宾显著减弱,并被两者联合使用所消除。这些结果表明突触后α2 - 肾上腺素能受体(除α1 - 肾上腺素能受体外)在体内静脉系统中起作用,并对静脉张力的肾上腺素能交感神经和体液调节有重要贡献。